Global Industry Analysts Inc., a publisher of off-the-shelf market research, reports that global demand for medicated skin care products is expected to post steady growth over the next few years. The ability of medicated skin care products to enhance the visual appeal of skin that suits the varied lifestyle requirements of consumers potentially denotes a very high-perceived value for these products in consumer mindsets, the firms says, and the functionality of medicated skin care products in effectively managing the beauty and skin care needs without impacting the skin health in various leisure and work milieus would continue to attract the consumers. The products are expected to ride high on this note, with manufacturers making every effort to delight consumers with enhanced value for their money.

The United States represents the largest regional market for medicated skin care products worldwide, as stated by the new market research report titled “Medicated Skin Care Products: A Global Strategic Business Report.” The US medicated skin care products market was one of the worst hit markets during the recession period. However, the market showed resilience during 2010 driven by mounting concerns for effective skincare among the US consumers. Europe constitutes the second largest market for medicated skin care products. Asia-Pacific represents the fastest growing market with sales projected to demonstrate a CAGR of 6.0% over the analysis period.

Among the medicated skin care product categories, Acne Treatment and anti-aging products are poised to show higher demand in the coming years. While acne bogs down the teen beauty, pre-mature ageing bothers the twenty-some things. Four-fifths of the world’s teen populace is victim to acne and is relying heavily on medicated creams that cleanse the skin blemish-free from acne and prevent recurrence, spelling an umpteen opportunity for medicated skin care products. Light and heat therapies is also making their debut with a big bang, all primed to drive away acne and pain. On the other hand, manufacturers are developing new products that prevent the onset of ageing by preventing loss of skin vitamins and collagen, and delay cell senescence and formation of wrinkles. The trend spells bountiful prospects for the newer ingredient actives incorporated in such products. Furthermore, manufacturers are upbeat about the cross industry partnerships among medical product companies that are set to devise solutions to effectively terminate skin problems.

Major players profiled in the report include Allergan Inc., avVaa World Health Care Products, Blistex Inc., Chattem Inc., ConvaTec, Galderma Pharma SA, Johnson & Johnson, Merck & Co., Neutrogena Corp, Novartis AG, Obagi Medical Products Inc., Procter & Gamble Company, Reckitt Benckiser Plc., Rohto Pharmaceutical Co. Ltd., Shiseido Co. Ltd., Stiefel Laboratories Inc., Unilever NV, and Wyeth Corp.

The research report provides a comprehensive review of the medicated skin care products markets, recession trends, current market trends, key growth drivers, product overview, recent product introductions, recent industry activity, and profiles of major/niche global as well as regional market participants. It provides annual sales estimates and projections for Medicated Skin Care Products market for the years 2007 through 2015 for the following geographic markets – US, Canada, Japan, Europe, Asia-Pacific, and Latin America. Also, a seven-year (2000-2006) historic analysis is provided for additional perspective.

For more details, visit www.strategyr.com/Medicated_Skin_Care_Products_Market_Report.asp